Search for: "RANBAXY INC"
Results 101 - 120
of 142
Sorted by Relevance
|
Sort by Date
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of Metropolitan… [read post]
1 Apr 2014, 9:50 pm
Earlier in 2013, generic-drug-maker Ranbaxy agreed to pay $500 million in fines and settlement costs after the company pled guilty to federal drug safety violations. [read post]
3 Jan 2014, 6:56 pm
Ranbaxy Inc., No. 10 Civ. 3734, 2012 WL 3853640, at *3 (S.D.N.Y. [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
21 Jun 2022, 12:18 am
Supp. 2d 138 (D.D.C. 2010); Ranbaxy Labs. [read post]
25 Jan 2019, 12:08 pm
MDL No. 2879 – In Re: Marriott International, Inc., Customer Data Security Breach Litigation. [read post]
25 Jan 2019, 12:08 pm
MDL No. 2879 – In Re: Marriott International, Inc., Customer Data Security Breach Litigation. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
5 Aug 2009, 5:35 am
. - Patent Docs) US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) US: Patents and data exclusivity: It ain’t necessarily so (Patent Docs) US: Teva fights for biotech generics (GenericsWeb) US bill considers access to Canadian pharmaceuticals (Pharmacapsules@Gowlings) US: Bilski and biotechnology – an update… [read post]
1 Feb 2012, 8:49 am
” Ranbaxy Pharm., Inc. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
12 Sep 2012, 5:00 am
Ranbaxy Pharmaceuticals, Inc., No. 3:11-cv-858-RCJ-VPC (D. [read post]
9 Oct 2018, 5:02 am
Is illegality of contingent-fee contract under Texas Gov’t Code § 82.065 arbitrable? [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
